|
|
|
Insider
Information: |
Hrynkow Sharon Hemond |
Relationship: |
Director |
City: |
Annandale |
State: |
VA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
33,205 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$33,459 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
33,205 |
|
|
Total
Value |
$33,459 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
Percentage
Gain/Loss : |
-37.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cyclo Therapeutics, Inc |
CYTH |
Chief Scientific Officer |
2021-03-29 |
18,350 |
2018-12-21 |
0 |
Premium* |
|
Forward Industries Inc |
FORD |
Director |
2022-12-20 |
14,855 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FORD |
Forward Industries Inc |
Director |
|
2022-02-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
% |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Scientific Officer |
|
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
7,350 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Scientific Officer |
|
2021-03-29 |
4 |
B |
$7.46 |
$7,460 |
D/D |
1,000 |
18,350 |
2.74 |
% |
|
FORD |
Forward Industries Inc |
Director |
|
2022-12-20 |
4 |
B |
$1.13 |
$11,282 |
D/D |
9,855 |
14,855 |
2.39 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Scientific Officer |
|
2019-07-31 |
4 |
B |
$0.24 |
$2,425 |
D/D |
10,000 |
325,000 |
2.66 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Scientific Officer |
|
2019-08-01 |
4 |
B |
$0.24 |
$2,475 |
D/D |
10,000 |
335,000 |
2.66 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Scientific Officer |
|
2021-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
17,350 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
SVP for Medical Affairs |
|
2018-12-21 |
4 |
B |
$0.00 |
$0 |
D/D |
40,000 |
275,000 |
2.66 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Scientific Officer |
|
2019-05-31 |
4 |
B |
$0.00 |
$0 |
D/D |
40,000 |
315,000 |
2.66 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Scientific Officer |
|
2019-09-27 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
435,000 |
0 |
- |
|
CYTH |
Cyclo Therapeutics, Inc |
Chief Scientific Officer |
|
2020-04-24 |
4 |
A |
$0.10 |
$20,000 |
D/D |
200,000 |
635,000 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|